Cargando…

The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma

Osteosarcoma (OS) is the most malignant bone tumor which mainly occurs in childhood or adolescence. The previous studies indicated that OS is difficult to treat. KIAA1429 is one of the components of m6A complex that regulating the process of m6A modification, which plays a crucial role in tumorigene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Jiaquan, Wang, Xuhua, Chen, Zhaoyuan, Zhou, Huaqiang, Xiao, Yihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006691/ https://www.ncbi.nlm.nih.gov/pubmed/36915895 http://dx.doi.org/10.1016/j.jbo.2023.100471

Ejemplares similares

The biological function of m6A methyltransferase KIAA1429 and its role in human disease
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

m(6)A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis
por: Xu, Ke, et al.
Publicado: (2023)

N(6)-methyladenosine (m(6)A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer
por: Tang, Jun, et al.
Publicado: (2021)

m(6)A methyltransferase KIAA1429 acts as an oncogenic factor in colorectal cancer by regulating SIRT1 in an m(6)A-dependent manner
por: Zhou, Yuan, et al.
Publicado: (2022)

m(6)A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA
por: Zhu, Zhongcheng, et al.
Publicado: (2022)

m6A ‘writer’ KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis
por: Rong, Jian, et al.
Publicado: (2022)

KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN
por: Meng, Yu, et al.
Publicado: (2023)

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
por: Ma, Chao, et al.
Publicado: (2023)

N(6)-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner
por: Li, Ying, et al.
Publicado: (2022)

N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression
por: Gan, Lijuan, et al.
Publicado: (2023)

Gene amplification‐driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A‐YTHDF2‐dependent in lung adenocarcinoma
por: Zhang, Chang, et al.
Publicado: (2022)

KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA
por: Cheng, Xiaoyu, et al.
Publicado: (2019)

LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway
por: Gong, Haoli, et al.
Publicado: (2023)

KIAA1429/VIRMA promotes breast cancer progression by m(6)A‐dependent cytosolic HAS2 stabilization
por: Li, Na, et al.
Publicado: (2023)

SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer
por: Zhang, Xu, et al.
Publicado: (2021)

KIAA1429 mediates epithelial mesenchymal transition in sorafenib‐resistant hepatocellular carcinoma through m6A methylation modification
por: Kuang, Ye, et al.
Publicado: (2022)

KIAA1429 regulates alternative splicing events of cancer-related genes in hepatocellular carcinoma
por: Liu, Zhao-chen, et al.
Publicado: (2022)

KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells
por: Wang, Luying, et al.
Publicado: (2023)

KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo–YAP pathway
por: Chen, Xiaomin, et al.
Publicado: (2023)

N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop
por: Ren, Saiyu, et al.
Publicado: (2022)

CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma
por: Tan, Kezhe, et al.
Publicado: (2023)

The m(6)A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy
por: Yao, Fangyi, et al.
Publicado: (2023)

KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
por: Lan, Tian, et al.
Publicado: (2019)

LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis
por: Wang, Xuhua, et al.
Publicado: (2022)

Unilateral biportal endoscopy versus microscopic decompression in the treatment of lumbar spinal stenosis: A meta-analysis
por: Zhou, Huaqiang, et al.
Publicado: (2022)

LncRNA HEIH expression in cancer prognosis: A review and meta-analysis
por: Wang, Xuhua, et al.
Publicado: (2023)

KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner
por: Wang, Peng, et al.
Publicado: (2021)

Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis
por: Li, Juncai, et al.
Publicado: (2023)

Serglycin promotes proliferation, migration, and invasion via the JAK/STAT signaling pathway in osteosarcoma
por: Lv, Bin, et al.
Publicado: (2021)

FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
por: Li, Xujun, et al.
Publicado: (2023)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway
por: Wang, Weiguo, et al.
Publicado: (2019)

Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway
por: Jia, Fei, et al.
Publicado: (2022)

PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
por: Lei, Zhong, et al.
Publicado: (2018)

TIAM2 promotes proliferation and invasion of osteosarcoma cells by activating the JAK2/STAT3 signaling pathway
por: Cheng, Shaohua, et al.
Publicado: (2022)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
por: Čokić, Vladan P., et al.
Publicado: (2015)

The role of IL-6/JAK2/STAT3 signaling pathway in cancers
por: Huang, Bei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rv1u5kglj27dpnqr1sdk8k4mcf